StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report published on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock. Calithera Biosciences Stock Performance CALA stock opened at $0.03 on Tuesday. The business has a 50 day simple moving average of $0.03 and a 200-day […]

Leave a Reply

Your email address will not be published.

Previous post Caesars Entertainment (NASDAQ:CZR) Earns Outperform Rating from Analysts at JMP Securities
Next post Immunome (NASDAQ:IMNM) Earns Outperform Rating from Wedbush